2020
DOI: 10.1002/cti2.1124
|View full text |Cite
|
Sign up to set email alerts
|

Immunosenescent characteristics of T cells in young patients following haploidentical haematopoietic stem cell transplantation from parental donors

Abstract: Immunosenescence in young HaploSCT patientsGH Lee et al.The conditioning regimen was composed of targeted busulfan with intensive pharmacokinetic monitoring, fludarabine (40 mg m À2 once daily via IV from days À8 to ª

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
16
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 75 publications
0
16
0
Order By: Relevance
“…Consequently, the prevalence of myelodysplasia and secondary malignancies increases after HSCT ( 64 ). An increase in senescent features and a reduction in cytokine production have been reported in T-cells of pediatric patients undergoing HSCT ( 48 ). Moreover, some studies have analyzed the effect of HSCT combined with total body irradiation or high-dose chemotherapy on the immune system of cancer patients.…”
Section: Effect Of Cancer Treatment Regimens On Immunosenescencementioning
confidence: 96%
“…Consequently, the prevalence of myelodysplasia and secondary malignancies increases after HSCT ( 64 ). An increase in senescent features and a reduction in cytokine production have been reported in T-cells of pediatric patients undergoing HSCT ( 48 ). Moreover, some studies have analyzed the effect of HSCT combined with total body irradiation or high-dose chemotherapy on the immune system of cancer patients.…”
Section: Effect Of Cancer Treatment Regimens On Immunosenescencementioning
confidence: 96%
“…Donor age has also been claimed to affect significantly the occurrence and the quality of CMV immune recovery ( 25 ), in accordance to investigation on healthy subjects that showed an evolution of CMV T-cell immunity with increasing age ( 32 , 33 ). These issues may have a particular impact on patients receiving parent-derived haploidentical HSCT ( 34 ). Since T-lymphocytes from patients failing to clear CMV had a poorer cytokine release after challenge with CMV antigens, quality of CMV immune recovery is supposed to play an important role in controlling CMV reactivation ( 35 ).…”
Section: Management Of Viral Infections After Hsctmentioning
confidence: 99%
“…Patient age over 50 years is commonly considered as an adverse risk factor ( 101 ). Moreover, attention has been driven to the possible lymphocyte senescence in case of parental donor, possibly leading to a reduced antiviral response ( 34 ). In a previous study, EBV reactivation was more common among HSCT recipients with gamma-interferon 3/3 genotype ( 102 ).…”
Section: Management Of Viral Infections After Hsctmentioning
confidence: 99%
“…The distinctive traits of adaptive immunosenescence include the decline of naïve lymphocytes and increasing antigen-experienced lymphocytes, especially of the memory phenotype. The senescent lymphocytes have limited capacity in eliminating novel antigens, have a pro-inflammatory cytokine profile, favors the development of autoimmunity and can evade apoptosis [ 86 , 98 , 99 , 100 , 101 ].…”
Section: Age-associated Changes In the Adaptive Immune Systemmentioning
confidence: 99%
“…The aging cells losing CD28 yet gaining CD57 is another characteristic of immunosenescence, which reflects its diminished capacity to proliferate [ 16 , 98 , 103 ]. Lee et al also noted that stimulated CD28- T cells produce larger amounts of pro-inflammatory IFN-γ and TNF-α [ 99 ]. Senescent T cells that lost the CD28 expression also show resistance to apoptosis and diminished caspase 3 activity in response to apoptotic stimuli.…”
Section: Age-associated Changes In the Adaptive Immune Systemmentioning
confidence: 99%